JAC Advance Access originally published online on July 1, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2003) 52, 176-179
© 2003 The British Society for Antimicrobial Chemotherapy
An RND-type multidrug efflux pump SdeXY from Serratia marcescens
Department of Microbiology, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama 700-8530, Japan
Received 18 March 2003; returned 18 April 2003; revised 28 April 2003; accepted 29 April 2003
Objectives: Serratia marcescens, an important cause of nosocomial infections, shows intrinsic resistance to a wide variety of antimicrobial agents (multidrug resistance). Multidrug efflux pumps are often involved in the multidrug resistance in many bacteria. A study was undertaken to characterize the multidrug efflux pumps in S. marcescens.
Methods: The genes responsible for the multidrug resistance phenotype in S. marcescens were cloned into Escherichia coli KAM32, a drug-hypersusceptible strain, for further analysis.
Results: We cloned sdeXY genes and determined the nucleotide sequence. Clones that carried the sdeXY genes displayed reduced susceptibility to several antimicrobial agents including erythromycin, tetracycline, norfloxacin, benzalkonium chloride, ethidium bromide, acriflavine and rhodamine 6G. A protein similarity search using GenBank revealed that SdeY is a member of the resistance nodulation cell-division (RND) family of multidrug efflux proteins and SdeX is a member of the membrane fusion proteins. Introduction of sdeXY into E. coli cells possessing tolC, but not in cells lacking tolC, resulted in multidrug resistance. We observed energy-dependent ethidium efflux in cells of E. coli KAM32 possessing sdeXY and tolC.
Conclusions: SdeXY is the first RND-type multidrug efflux pump to be characterized in multidrug-resistant S. marcescens.
Keywords: SdeXY, multidrug efflux pump, RND family, S. marcescens
* Corresponding author. Tel/Fax: +81-86-251-7957; E-mail: tsuchiya{at}pharm.okayama-u.ac.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. K. Aoki, J. S. Webb, B. A. Braaten, and D. A. Low Contact-Dependent Growth Inhibition Causes Reversible Metabolic Downregulation in Escherichia coli J. Bacteriol., March 15, 2009; 191(6): 1777 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Begic and E. A. Worobec The role of the Serratia marcescens SdeAB multidrug efflux pump and TolC homologue in fluoroquinolone resistance studied via gene-knockout mutagenesis Microbiology, February 1, 2008; 154(2): 454 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuo, J. Chen, Y. Minato, W. Ogawa, T. Mizushima, T. Kuroda, and T. Tsuchiya SmdAB, a Heterodimeric ABC-Type Multidrug Efflux Pump, in Serratia marcescens J. Bacteriol., January 15, 2008; 190(2): 648 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuo, K. Hayashi, Y. Morita, M. Koterasawa, W. Ogawa, T. Mizushima, T. Tsuchiya, and T. Kuroda VmeAB, an RND-type multidrug efflux transporter in Vibrio parahaemolyticus Microbiology, December 1, 2007; 153(12): 4129 - 4137. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schumacher, P. Steinke, J. A. Bohnert, M. Akova, D. Jonas, and W. V. Kern Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli J. Antimicrob. Chemother., February 1, 2006; 57(2): 344 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Poole Efflux-mediated antimicrobial resistance J. Antimicrob. Chemother., July 1, 2005; 56(1): 20 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar and E. A. Worobec Cloning, Sequencing, and Characterization of the SdeAB Multidrug Efflux Pump of Serratia marcescens Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1495 - 1501. [Abstract] [Full Text] [PDF] |
||||



